nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PGD—Dacarbazine—pancreatic cancer	0.346	0.614	CbGbCtD
Meloxicam—PTGS2—pancreatic cancer	0.254	1	CbGaD
Meloxicam—ABCC4—Fluorouracil—pancreatic cancer	0.0559	0.0993	CbGbCtD
Meloxicam—ABCC4—Sunitinib—pancreatic cancer	0.0425	0.0754	CbGbCtD
Meloxicam—CYP2C8—Tamoxifen—pancreatic cancer	0.0217	0.0386	CbGbCtD
Meloxicam—CYP2C8—Erlotinib—pancreatic cancer	0.0185	0.0328	CbGbCtD
Meloxicam—CYP2C8—Fluorouracil—pancreatic cancer	0.016	0.0284	CbGbCtD
Meloxicam—CYP2C9—Tamoxifen—pancreatic cancer	0.0152	0.0269	CbGbCtD
Meloxicam—CYP2C9—Fluorouracil—pancreatic cancer	0.0112	0.0198	CbGbCtD
Meloxicam—CYP3A4—Tamoxifen—pancreatic cancer	0.00882	0.0156	CbGbCtD
Meloxicam—CYP3A4—Erlotinib—pancreatic cancer	0.0075	0.0133	CbGbCtD
Meloxicam—CYP3A4—Irinotecan—pancreatic cancer	0.00677	0.012	CbGbCtD
Meloxicam—CYP3A4—Docetaxel—pancreatic cancer	0.00496	0.00881	CbGbCtD
Meloxicam—CYP3A4—Sunitinib—pancreatic cancer	0.00494	0.00877	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—pancreatic cancer	0.0037	0.00656	CbGbCtD
Meloxicam—Lornoxicam—PTGS2—pancreatic cancer	0.000997	0.41	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—pancreatic cancer	0.000888	0.365	CrCbGaD
Meloxicam—Piroxicam—PTGS2—pancreatic cancer	0.000549	0.226	CrCbGaD
Meloxicam—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	8.77e-05	0.000533	CcSEcCtD
Meloxicam—Sweating—Epirubicin—pancreatic cancer	8.72e-05	0.00053	CcSEcCtD
Meloxicam—Pollakiuria—Doxorubicin—pancreatic cancer	8.72e-05	0.00053	CcSEcCtD
Meloxicam—Asthenia—Gemcitabine—pancreatic cancer	8.7e-05	0.000528	CcSEcCtD
Meloxicam—Haematuria—Epirubicin—pancreatic cancer	8.67e-05	0.000527	CcSEcCtD
Meloxicam—Confusional state—Docetaxel—pancreatic cancer	8.67e-05	0.000527	CcSEcCtD
Meloxicam—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.62e-05	0.000523	CcSEcCtD
Meloxicam—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.6e-05	0.000523	CcSEcCtD
Meloxicam—Oedema—Docetaxel—pancreatic cancer	8.6e-05	0.000523	CcSEcCtD
Meloxicam—Anaphylactic shock—Docetaxel—pancreatic cancer	8.6e-05	0.000523	CcSEcCtD
Meloxicam—Weight increased—Doxorubicin—pancreatic cancer	8.59e-05	0.000522	CcSEcCtD
Meloxicam—Pruritus—Gemcitabine—pancreatic cancer	8.58e-05	0.000521	CcSEcCtD
Meloxicam—Infection—Docetaxel—pancreatic cancer	8.55e-05	0.000519	CcSEcCtD
Meloxicam—Weight decreased—Doxorubicin—pancreatic cancer	8.54e-05	0.000519	CcSEcCtD
Meloxicam—Sinusitis—Epirubicin—pancreatic cancer	8.53e-05	0.000518	CcSEcCtD
Meloxicam—Diarrhoea—Irinotecan—pancreatic cancer	8.51e-05	0.000517	CcSEcCtD
Meloxicam—Agranulocytosis—Epirubicin—pancreatic cancer	8.49e-05	0.000516	CcSEcCtD
Meloxicam—Shock—Docetaxel—pancreatic cancer	8.46e-05	0.000514	CcSEcCtD
Meloxicam—Nervous system disorder—Docetaxel—pancreatic cancer	8.44e-05	0.000512	CcSEcCtD
Meloxicam—Pruritus—Fluorouracil—pancreatic cancer	8.43e-05	0.000512	CcSEcCtD
Meloxicam—Thrombocytopenia—Docetaxel—pancreatic cancer	8.42e-05	0.000512	CcSEcCtD
Meloxicam—Infestation—Doxorubicin—pancreatic cancer	8.42e-05	0.000511	CcSEcCtD
Meloxicam—Infestation NOS—Doxorubicin—pancreatic cancer	8.42e-05	0.000511	CcSEcCtD
Meloxicam—Drowsiness—Doxorubicin—pancreatic cancer	8.42e-05	0.000511	CcSEcCtD
Meloxicam—Tachycardia—Docetaxel—pancreatic cancer	8.4e-05	0.00051	CcSEcCtD
Meloxicam—Skin disorder—Docetaxel—pancreatic cancer	8.36e-05	0.000508	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.35e-05	0.000507	CcSEcCtD
Meloxicam—Diarrhoea—Gemcitabine—pancreatic cancer	8.29e-05	0.000504	CcSEcCtD
Meloxicam—Renal failure—Doxorubicin—pancreatic cancer	8.27e-05	0.000503	CcSEcCtD
Meloxicam—Dizziness—Irinotecan—pancreatic cancer	8.23e-05	0.0005	CcSEcCtD
Meloxicam—Haemoglobin—Epirubicin—pancreatic cancer	8.21e-05	0.000499	CcSEcCtD
Meloxicam—Stomatitis—Doxorubicin—pancreatic cancer	8.2e-05	0.000498	CcSEcCtD
Meloxicam—Jaundice—Doxorubicin—pancreatic cancer	8.2e-05	0.000498	CcSEcCtD
Meloxicam—Rhinitis—Epirubicin—pancreatic cancer	8.19e-05	0.000497	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—pancreatic cancer	8.18e-05	0.000497	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—pancreatic cancer	8.18e-05	0.000497	CcSEcCtD
Meloxicam—Haemorrhage—Epirubicin—pancreatic cancer	8.17e-05	0.000496	CcSEcCtD
Meloxicam—Hepatitis—Epirubicin—pancreatic cancer	8.17e-05	0.000496	CcSEcCtD
Meloxicam—Diarrhoea—Fluorouracil—pancreatic cancer	8.15e-05	0.000495	CcSEcCtD
Meloxicam—Pharyngitis—Epirubicin—pancreatic cancer	8.11e-05	0.000492	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—pancreatic cancer	8.07e-05	0.00049	CcSEcCtD
Meloxicam—Urinary tract disorder—Epirubicin—pancreatic cancer	8.06e-05	0.00049	CcSEcCtD
Meloxicam—Oedema peripheral—Epirubicin—pancreatic cancer	8.04e-05	0.000489	CcSEcCtD
Meloxicam—Hypotension—Docetaxel—pancreatic cancer	8.04e-05	0.000488	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—pancreatic cancer	8.03e-05	0.000488	CcSEcCtD
Meloxicam—Connective tissue disorder—Epirubicin—pancreatic cancer	8.03e-05	0.000488	CcSEcCtD
Meloxicam—Urethral disorder—Epirubicin—pancreatic cancer	8.01e-05	0.000486	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.96e-05	0.000484	CcSEcCtD
Meloxicam—Vomiting—Irinotecan—pancreatic cancer	7.91e-05	0.000481	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—pancreatic cancer	7.9e-05	0.00048	CcSEcCtD
Meloxicam—Dizziness—Fluorouracil—pancreatic cancer	7.88e-05	0.000479	CcSEcCtD
Meloxicam—Visual impairment—Epirubicin—pancreatic cancer	7.87e-05	0.000478	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—pancreatic cancer	7.86e-05	0.000477	CcSEcCtD
Meloxicam—Rash—Irinotecan—pancreatic cancer	7.85e-05	0.000477	CcSEcCtD
Meloxicam—Dermatitis—Irinotecan—pancreatic cancer	7.84e-05	0.000476	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.84e-05	0.000476	CcSEcCtD
Meloxicam—Headache—Irinotecan—pancreatic cancer	7.8e-05	0.000474	CcSEcCtD
Meloxicam—Insomnia—Docetaxel—pancreatic cancer	7.78e-05	0.000473	CcSEcCtD
Meloxicam—Paraesthesia—Docetaxel—pancreatic cancer	7.72e-05	0.000469	CcSEcCtD
Meloxicam—Erythema multiforme—Epirubicin—pancreatic cancer	7.72e-05	0.000469	CcSEcCtD
Meloxicam—Vomiting—Gemcitabine—pancreatic cancer	7.71e-05	0.000468	CcSEcCtD
Meloxicam—Dyspnoea—Docetaxel—pancreatic cancer	7.67e-05	0.000466	CcSEcCtD
Meloxicam—Somnolence—Docetaxel—pancreatic cancer	7.65e-05	0.000465	CcSEcCtD
Meloxicam—Rash—Gemcitabine—pancreatic cancer	7.64e-05	0.000464	CcSEcCtD
Meloxicam—Dermatitis—Gemcitabine—pancreatic cancer	7.64e-05	0.000464	CcSEcCtD
Meloxicam—Eye disorder—Epirubicin—pancreatic cancer	7.63e-05	0.000464	CcSEcCtD
Meloxicam—Tinnitus—Epirubicin—pancreatic cancer	7.61e-05	0.000463	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—pancreatic cancer	7.59e-05	0.000461	CcSEcCtD
Meloxicam—Headache—Gemcitabine—pancreatic cancer	7.59e-05	0.000461	CcSEcCtD
Meloxicam—Cardiac disorder—Epirubicin—pancreatic cancer	7.58e-05	0.00046	CcSEcCtD
Meloxicam—Flushing—Epirubicin—pancreatic cancer	7.58e-05	0.00046	CcSEcCtD
Meloxicam—Vomiting—Fluorouracil—pancreatic cancer	7.58e-05	0.00046	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—pancreatic cancer	7.58e-05	0.00046	CcSEcCtD
Meloxicam—Dyspepsia—Docetaxel—pancreatic cancer	7.57e-05	0.00046	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—pancreatic cancer	7.56e-05	0.000459	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—pancreatic cancer	7.56e-05	0.000459	CcSEcCtD
Meloxicam—Rash—Fluorouracil—pancreatic cancer	7.51e-05	0.000456	CcSEcCtD
Meloxicam—Dermatitis—Fluorouracil—pancreatic cancer	7.51e-05	0.000456	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—pancreatic cancer	7.5e-05	0.000456	CcSEcCtD
Meloxicam—Decreased appetite—Docetaxel—pancreatic cancer	7.48e-05	0.000454	CcSEcCtD
Meloxicam—Headache—Fluorouracil—pancreatic cancer	7.47e-05	0.000454	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.46e-05	0.000453	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—pancreatic cancer	7.44e-05	0.000452	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.43e-05	0.000451	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.43e-05	0.000451	CcSEcCtD
Meloxicam—Fatigue—Docetaxel—pancreatic cancer	7.42e-05	0.000451	CcSEcCtD
Meloxicam—Angiopathy—Epirubicin—pancreatic cancer	7.41e-05	0.00045	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—pancreatic cancer	7.41e-05	0.00045	CcSEcCtD
Meloxicam—Nausea—Irinotecan—pancreatic cancer	7.39e-05	0.000449	CcSEcCtD
Meloxicam—Immune system disorder—Epirubicin—pancreatic cancer	7.38e-05	0.000448	CcSEcCtD
Meloxicam—Mediastinal disorder—Epirubicin—pancreatic cancer	7.36e-05	0.000447	CcSEcCtD
Meloxicam—Pain—Docetaxel—pancreatic cancer	7.36e-05	0.000447	CcSEcCtD
Meloxicam—Constipation—Docetaxel—pancreatic cancer	7.36e-05	0.000447	CcSEcCtD
Meloxicam—Arrhythmia—Epirubicin—pancreatic cancer	7.3e-05	0.000443	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—pancreatic cancer	7.28e-05	0.000442	CcSEcCtD
Meloxicam—Alopecia—Epirubicin—pancreatic cancer	7.22e-05	0.000438	CcSEcCtD
Meloxicam—Nausea—Gemcitabine—pancreatic cancer	7.2e-05	0.000437	CcSEcCtD
Meloxicam—Mental disorder—Epirubicin—pancreatic cancer	7.15e-05	0.000435	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—pancreatic cancer	7.14e-05	0.000434	CcSEcCtD
Meloxicam—Erythema—Epirubicin—pancreatic cancer	7.11e-05	0.000432	CcSEcCtD
Meloxicam—Malnutrition—Epirubicin—pancreatic cancer	7.11e-05	0.000432	CcSEcCtD
Meloxicam—Feeling abnormal—Docetaxel—pancreatic cancer	7.09e-05	0.000431	CcSEcCtD
Meloxicam—Nausea—Fluorouracil—pancreatic cancer	7.08e-05	0.00043	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—pancreatic cancer	7.06e-05	0.000429	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—pancreatic cancer	7.05e-05	0.000428	CcSEcCtD
Meloxicam—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.03e-05	0.000427	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—pancreatic cancer	7.01e-05	0.000426	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—pancreatic cancer	7.01e-05	0.000426	CcSEcCtD
Meloxicam—Flatulence—Epirubicin—pancreatic cancer	7.01e-05	0.000426	CcSEcCtD
Meloxicam—Tension—Epirubicin—pancreatic cancer	6.98e-05	0.000424	CcSEcCtD
Meloxicam—Dysgeusia—Epirubicin—pancreatic cancer	6.96e-05	0.000423	CcSEcCtD
Meloxicam—Nervousness—Epirubicin—pancreatic cancer	6.9e-05	0.000419	CcSEcCtD
Meloxicam—Back pain—Epirubicin—pancreatic cancer	6.88e-05	0.000418	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—pancreatic cancer	6.86e-05	0.000416	CcSEcCtD
Meloxicam—Muscle spasms—Epirubicin—pancreatic cancer	6.83e-05	0.000415	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—pancreatic cancer	6.83e-05	0.000415	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.81e-05	0.000414	CcSEcCtD
Meloxicam—Abdominal pain—Docetaxel—pancreatic cancer	6.8e-05	0.000413	CcSEcCtD
Meloxicam—Body temperature increased—Docetaxel—pancreatic cancer	6.8e-05	0.000413	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—pancreatic cancer	6.75e-05	0.00041	CcSEcCtD
Meloxicam—Vision blurred—Epirubicin—pancreatic cancer	6.7e-05	0.000407	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—pancreatic cancer	6.68e-05	0.000406	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—pancreatic cancer	6.62e-05	0.000402	CcSEcCtD
Meloxicam—Ill-defined disorder—Epirubicin—pancreatic cancer	6.6e-05	0.000401	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—pancreatic cancer	6.58e-05	0.0004	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—pancreatic cancer	6.58e-05	0.0004	CcSEcCtD
Meloxicam—Anaemia—Epirubicin—pancreatic cancer	6.57e-05	0.000399	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—pancreatic cancer	6.48e-05	0.000394	CcSEcCtD
Meloxicam—Tension—Doxorubicin—pancreatic cancer	6.45e-05	0.000392	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—pancreatic cancer	6.44e-05	0.000391	CcSEcCtD
Meloxicam—Malaise—Epirubicin—pancreatic cancer	6.41e-05	0.000389	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—pancreatic cancer	6.39e-05	0.000388	CcSEcCtD
Meloxicam—Vertigo—Epirubicin—pancreatic cancer	6.39e-05	0.000388	CcSEcCtD
Meloxicam—Syncope—Epirubicin—pancreatic cancer	6.38e-05	0.000387	CcSEcCtD
Meloxicam—Leukopenia—Epirubicin—pancreatic cancer	6.36e-05	0.000387	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—pancreatic cancer	6.36e-05	0.000387	CcSEcCtD
Meloxicam—Hypersensitivity—Docetaxel—pancreatic cancer	6.34e-05	0.000385	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—pancreatic cancer	6.32e-05	0.000384	CcSEcCtD
Meloxicam—Palpitations—Epirubicin—pancreatic cancer	6.28e-05	0.000382	CcSEcCtD
Meloxicam—Loss of consciousness—Epirubicin—pancreatic cancer	6.25e-05	0.00038	CcSEcCtD
Meloxicam—Cough—Epirubicin—pancreatic cancer	6.2e-05	0.000377	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—pancreatic cancer	6.2e-05	0.000377	CcSEcCtD
Meloxicam—Asthenia—Docetaxel—pancreatic cancer	6.17e-05	0.000375	CcSEcCtD
Meloxicam—Convulsion—Epirubicin—pancreatic cancer	6.16e-05	0.000374	CcSEcCtD
Meloxicam—Hypertension—Epirubicin—pancreatic cancer	6.14e-05	0.000373	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.1e-05	0.000371	CcSEcCtD
Meloxicam—Pruritus—Docetaxel—pancreatic cancer	6.09e-05	0.00037	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—pancreatic cancer	6.08e-05	0.000369	CcSEcCtD
Meloxicam—Arthralgia—Epirubicin—pancreatic cancer	6.05e-05	0.000368	CcSEcCtD
Meloxicam—Myalgia—Epirubicin—pancreatic cancer	6.05e-05	0.000368	CcSEcCtD
Meloxicam—Anxiety—Epirubicin—pancreatic cancer	6.03e-05	0.000366	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.01e-05	0.000365	CcSEcCtD
Meloxicam—Discomfort—Epirubicin—pancreatic cancer	5.98e-05	0.000363	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—pancreatic cancer	5.93e-05	0.00036	CcSEcCtD
Meloxicam—Dry mouth—Epirubicin—pancreatic cancer	5.92e-05	0.00036	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—pancreatic cancer	5.91e-05	0.000359	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—pancreatic cancer	5.9e-05	0.000358	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—pancreatic cancer	5.89e-05	0.000358	CcSEcCtD
Meloxicam—Diarrhoea—Docetaxel—pancreatic cancer	5.89e-05	0.000358	CcSEcCtD
Meloxicam—Confusional state—Epirubicin—pancreatic cancer	5.85e-05	0.000355	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—pancreatic cancer	5.81e-05	0.000353	CcSEcCtD
Meloxicam—Anaphylactic shock—Epirubicin—pancreatic cancer	5.8e-05	0.000352	CcSEcCtD
Meloxicam—Oedema—Epirubicin—pancreatic cancer	5.8e-05	0.000352	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—pancreatic cancer	5.78e-05	0.000351	CcSEcCtD
Meloxicam—Infection—Epirubicin—pancreatic cancer	5.76e-05	0.00035	CcSEcCtD
Meloxicam—Cough—Doxorubicin—pancreatic cancer	5.74e-05	0.000349	CcSEcCtD
Meloxicam—Shock—Epirubicin—pancreatic cancer	5.71e-05	0.000347	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—pancreatic cancer	5.7e-05	0.000346	CcSEcCtD
Meloxicam—Nervous system disorder—Epirubicin—pancreatic cancer	5.69e-05	0.000346	CcSEcCtD
Meloxicam—Dizziness—Docetaxel—pancreatic cancer	5.69e-05	0.000346	CcSEcCtD
Meloxicam—Thrombocytopenia—Epirubicin—pancreatic cancer	5.68e-05	0.000345	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—pancreatic cancer	5.68e-05	0.000345	CcSEcCtD
Meloxicam—Tachycardia—Epirubicin—pancreatic cancer	5.66e-05	0.000344	CcSEcCtD
Meloxicam—Skin disorder—Epirubicin—pancreatic cancer	5.64e-05	0.000342	CcSEcCtD
Meloxicam—Hyperhidrosis—Epirubicin—pancreatic cancer	5.61e-05	0.000341	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—pancreatic cancer	5.6e-05	0.00034	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—pancreatic cancer	5.6e-05	0.00034	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—pancreatic cancer	5.58e-05	0.000339	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.56e-05	0.000338	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—pancreatic cancer	5.53e-05	0.000336	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—pancreatic cancer	5.48e-05	0.000333	CcSEcCtD
Meloxicam—Vomiting—Docetaxel—pancreatic cancer	5.47e-05	0.000332	CcSEcCtD
Meloxicam—Rash—Docetaxel—pancreatic cancer	5.42e-05	0.000329	CcSEcCtD
Meloxicam—Hypotension—Epirubicin—pancreatic cancer	5.42e-05	0.000329	CcSEcCtD
Meloxicam—Dermatitis—Docetaxel—pancreatic cancer	5.42e-05	0.000329	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—pancreatic cancer	5.41e-05	0.000329	CcSEcCtD
Meloxicam—Headache—Docetaxel—pancreatic cancer	5.39e-05	0.000327	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—pancreatic cancer	5.37e-05	0.000326	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.37e-05	0.000326	CcSEcCtD
Meloxicam—Infection—Doxorubicin—pancreatic cancer	5.33e-05	0.000324	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.29e-05	0.000321	CcSEcCtD
Meloxicam—Shock—Doxorubicin—pancreatic cancer	5.28e-05	0.000321	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—pancreatic cancer	5.26e-05	0.00032	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.26e-05	0.000319	CcSEcCtD
Meloxicam—Insomnia—Epirubicin—pancreatic cancer	5.25e-05	0.000319	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—pancreatic cancer	5.24e-05	0.000318	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—pancreatic cancer	5.21e-05	0.000317	CcSEcCtD
Meloxicam—Paraesthesia—Epirubicin—pancreatic cancer	5.21e-05	0.000316	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.19e-05	0.000315	CcSEcCtD
Meloxicam—Dyspnoea—Epirubicin—pancreatic cancer	5.17e-05	0.000314	CcSEcCtD
Meloxicam—Somnolence—Epirubicin—pancreatic cancer	5.16e-05	0.000313	CcSEcCtD
Meloxicam—Nausea—Docetaxel—pancreatic cancer	5.11e-05	0.00031	CcSEcCtD
Meloxicam—Dyspepsia—Epirubicin—pancreatic cancer	5.11e-05	0.00031	CcSEcCtD
Meloxicam—Decreased appetite—Epirubicin—pancreatic cancer	5.04e-05	0.000306	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—pancreatic cancer	5.02e-05	0.000305	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.01e-05	0.000304	CcSEcCtD
Meloxicam—Fatigue—Epirubicin—pancreatic cancer	5e-05	0.000304	CcSEcCtD
Meloxicam—Pain—Epirubicin—pancreatic cancer	4.96e-05	0.000301	CcSEcCtD
Meloxicam—Constipation—Epirubicin—pancreatic cancer	4.96e-05	0.000301	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.89e-05	0.000297	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—pancreatic cancer	4.86e-05	0.000295	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—pancreatic cancer	4.82e-05	0.000293	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—pancreatic cancer	4.79e-05	0.000291	CcSEcCtD
Meloxicam—Feeling abnormal—Epirubicin—pancreatic cancer	4.78e-05	0.00029	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—pancreatic cancer	4.77e-05	0.00029	CcSEcCtD
Meloxicam—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.74e-05	0.000288	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—pancreatic cancer	4.73e-05	0.000287	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—pancreatic cancer	4.67e-05	0.000283	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.63e-05	0.000282	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—pancreatic cancer	4.63e-05	0.000281	CcSEcCtD
Meloxicam—Urticaria—Epirubicin—pancreatic cancer	4.61e-05	0.00028	CcSEcCtD
Meloxicam—Pain—Doxorubicin—pancreatic cancer	4.59e-05	0.000279	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—pancreatic cancer	4.59e-05	0.000279	CcSEcCtD
Meloxicam—Abdominal pain—Epirubicin—pancreatic cancer	4.59e-05	0.000279	CcSEcCtD
Meloxicam—Body temperature increased—Epirubicin—pancreatic cancer	4.59e-05	0.000279	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—pancreatic cancer	4.42e-05	0.000269	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.39e-05	0.000267	CcSEcCtD
Meloxicam—Hypersensitivity—Epirubicin—pancreatic cancer	4.27e-05	0.00026	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—pancreatic cancer	4.26e-05	0.000259	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—pancreatic cancer	4.24e-05	0.000258	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—pancreatic cancer	4.24e-05	0.000258	CcSEcCtD
Meloxicam—Asthenia—Epirubicin—pancreatic cancer	4.16e-05	0.000253	CcSEcCtD
Meloxicam—Pruritus—Epirubicin—pancreatic cancer	4.1e-05	0.000249	CcSEcCtD
Meloxicam—Diarrhoea—Epirubicin—pancreatic cancer	3.97e-05	0.000241	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—pancreatic cancer	3.96e-05	0.00024	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—pancreatic cancer	3.85e-05	0.000234	CcSEcCtD
Meloxicam—Dizziness—Epirubicin—pancreatic cancer	3.84e-05	0.000233	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—pancreatic cancer	3.8e-05	0.000231	CcSEcCtD
Meloxicam—Vomiting—Epirubicin—pancreatic cancer	3.69e-05	0.000224	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—pancreatic cancer	3.67e-05	0.000223	CcSEcCtD
Meloxicam—Rash—Epirubicin—pancreatic cancer	3.66e-05	0.000222	CcSEcCtD
Meloxicam—Dermatitis—Epirubicin—pancreatic cancer	3.65e-05	0.000222	CcSEcCtD
Meloxicam—Headache—Epirubicin—pancreatic cancer	3.63e-05	0.000221	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—pancreatic cancer	3.55e-05	0.000216	CcSEcCtD
Meloxicam—Nausea—Epirubicin—pancreatic cancer	3.45e-05	0.000209	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—pancreatic cancer	3.41e-05	0.000207	CcSEcCtD
Meloxicam—Rash—Doxorubicin—pancreatic cancer	3.38e-05	0.000206	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—pancreatic cancer	3.38e-05	0.000205	CcSEcCtD
Meloxicam—Headache—Doxorubicin—pancreatic cancer	3.36e-05	0.000204	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—pancreatic cancer	3.19e-05	0.000194	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—CCND1—pancreatic cancer	2.9e-05	0.00184	CbGpPWpGaD
Meloxicam—PGD—Metabolism—STK11—pancreatic cancer	2.9e-05	0.00184	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IFNA2—pancreatic cancer	2.84e-05	0.00181	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—MYC—pancreatic cancer	2.79e-05	0.00178	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	2.67e-05	0.0017	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—pancreatic cancer	2.66e-05	0.0017	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—pancreatic cancer	2.63e-05	0.00167	CbGpPWpGaD
Meloxicam—PGD—Disease—TERT—pancreatic cancer	2.59e-05	0.00165	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	2.5e-05	0.00159	CbGpPWpGaD
Meloxicam—PGD—Metabolism—TYMS—pancreatic cancer	2.49e-05	0.00159	CbGpPWpGaD
Meloxicam—PGD—Disease—HIF1A—pancreatic cancer	2.48e-05	0.00158	CbGpPWpGaD
Meloxicam—PGD—Disease—TSC2—pancreatic cancer	2.47e-05	0.00157	CbGpPWpGaD
Meloxicam—PGD—Disease—APOE—pancreatic cancer	2.42e-05	0.00154	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	2.37e-05	0.00151	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	2.32e-05	0.00148	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	2.27e-05	0.00144	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.26e-05	0.00144	CbGpPWpGaD
Meloxicam—PGD—Disease—NOTCH1—pancreatic cancer	2.23e-05	0.00142	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	2.21e-05	0.0014	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.16e-05	0.00138	CbGpPWpGaD
Meloxicam—PGD—Disease—EGF—pancreatic cancer	2.16e-05	0.00137	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	2.15e-05	0.00137	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	2.14e-05	0.00136	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.14e-05	0.00136	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	2.09e-05	0.00133	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.08e-05	0.00133	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PRSS1—pancreatic cancer	2.04e-05	0.0013	CbGpPWpGaD
Meloxicam—PGD—Metabolism—APOE—pancreatic cancer	2.03e-05	0.00129	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PLAU—pancreatic cancer	2.02e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PRSS1—pancreatic cancer	1.93e-05	0.00123	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ZNRF3—pancreatic cancer	1.93e-05	0.00123	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CD—pancreatic cancer	1.92e-05	0.00122	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.91e-05	0.00122	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CG—pancreatic cancer	1.83e-05	0.00116	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	1.83e-05	0.00116	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	1.8e-05	0.00114	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—EGF—pancreatic cancer	1.77e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	1.77e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ARG2—pancreatic cancer	1.77e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	1.77e-05	0.00112	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PPARG—pancreatic cancer	1.76e-05	0.00112	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DTX1—pancreatic cancer	1.75e-05	0.00111	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	1.73e-05	0.0011	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CB—pancreatic cancer	1.67e-05	0.00106	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—pancreatic cancer	1.66e-05	0.00105	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	1.65e-05	0.00105	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.63e-05	0.00104	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PRSS1—pancreatic cancer	1.62e-05	0.00103	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CD—pancreatic cancer	1.61e-05	0.00102	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	1.58e-05	0.001	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMP—pancreatic cancer	1.55e-05	0.000984	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.54e-05	0.000982	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.5e-05	0.000956	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.49e-05	0.000946	CbGpPWpGaD
Meloxicam—PGD—Disease—CTNNB1—pancreatic cancer	1.48e-05	0.000944	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DTX4—pancreatic cancer	1.47e-05	0.000933	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	1.45e-05	0.000925	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.45e-05	0.000922	CbGpPWpGaD
Meloxicam—PGD—Disease—PTEN—pancreatic cancer	1.45e-05	0.00092	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPP2R5B—pancreatic cancer	1.43e-05	0.000907	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ARG2—pancreatic cancer	1.4e-05	0.000894	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CB—pancreatic cancer	1.4e-05	0.000892	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—pancreatic cancer	1.39e-05	0.000883	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	1.38e-05	0.000875	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HEY2—pancreatic cancer	1.37e-05	0.000873	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.34e-05	0.000855	CbGpPWpGaD
Meloxicam—PGD—Disease—SRC—pancreatic cancer	1.34e-05	0.000853	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.33e-05	0.000846	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.32e-05	0.000839	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.31e-05	0.000833	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT3—pancreatic cancer	1.29e-05	0.000823	CbGpPWpGaD
Meloxicam—PGD—Disease—NRAS—pancreatic cancer	1.29e-05	0.000821	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.28e-05	0.000812	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HEY1—pancreatic cancer	1.27e-05	0.000809	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GLP1R—pancreatic cancer	1.25e-05	0.000793	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMP—pancreatic cancer	1.23e-05	0.000781	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DPYD—pancreatic cancer	1.23e-05	0.00078	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTEN—pancreatic cancer	1.21e-05	0.00077	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.2e-05	0.000767	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.2e-05	0.000765	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—pancreatic cancer	1.2e-05	0.000765	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—pancreatic cancer	1.2e-05	0.000763	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.18e-05	0.00075	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—pancreatic cancer	1.18e-05	0.000748	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC2A2—pancreatic cancer	1.16e-05	0.000741	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.15e-05	0.000733	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.14e-05	0.000727	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JAG2—pancreatic cancer	1.13e-05	0.000717	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.12e-05	0.000714	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.11e-05	0.000708	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.11e-05	0.000707	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MEN1—pancreatic cancer	1.11e-05	0.000707	CbGpPWpGaD
Meloxicam—PGD—Disease—KRAS—pancreatic cancer	1.11e-05	0.000706	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC2A2—pancreatic cancer	1.1e-05	0.000702	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SRC—pancreatic cancer	1.1e-05	0.000702	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—pancreatic cancer	1.07e-05	0.000683	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.07e-05	0.000683	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NRAS—pancreatic cancer	1.06e-05	0.000675	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SHH—pancreatic cancer	1.06e-05	0.000674	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IAPP—pancreatic cancer	1.05e-05	0.000666	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.02e-05	0.000651	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—pancreatic cancer	1.02e-05	0.000649	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.01e-05	0.000645	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.01e-05	0.000644	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HSPA1B—pancreatic cancer	1e-05	0.000639	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMP—pancreatic cancer	9.99e-06	0.000636	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GLP1R—pancreatic cancer	9.89e-06	0.00063	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.89e-06	0.00063	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—pancreatic cancer	9.85e-06	0.000627	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DPYD—pancreatic cancer	9.73e-06	0.000619	CbGpPWpGaD
Meloxicam—PGD—Disease—HRAS—pancreatic cancer	9.44e-06	0.0006	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ARG2—pancreatic cancer	9.3e-06	0.000592	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC2A2—pancreatic cancer	9.24e-06	0.000588	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.14e-06	0.000582	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—KRAS—pancreatic cancer	9.13e-06	0.000581	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD44—pancreatic cancer	9.01e-06	0.000573	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JAG1—pancreatic cancer	8.99e-06	0.000572	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.82e-06	0.000562	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.82e-06	0.000561	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.74e-06	0.000556	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GCG—pancreatic cancer	8.64e-06	0.00055	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD44—pancreatic cancer	8.54e-06	0.000544	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—pancreatic cancer	8.54e-06	0.000544	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HSPA1A—pancreatic cancer	8.48e-06	0.00054	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	8.39e-06	0.000534	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.35e-06	0.000532	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—pancreatic cancer	8.33e-06	0.00053	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.24e-06	0.000525	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMP—pancreatic cancer	8.13e-06	0.000517	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—STK11—pancreatic cancer	8.12e-06	0.000517	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—pancreatic cancer	8.11e-06	0.000516	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GLP1R—pancreatic cancer	8.05e-06	0.000512	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.04e-06	0.000511	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DPYD—pancreatic cancer	7.92e-06	0.000504	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—pancreatic cancer	7.76e-06	0.000494	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.62e-06	0.000485	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	7.52e-06	0.000478	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.44e-06	0.000473	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.18e-06	0.000457	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD44—pancreatic cancer	7.15e-06	0.000455	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.07e-06	0.00045	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7e-06	0.000446	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMS—pancreatic cancer	6.99e-06	0.000445	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—pancreatic cancer	6.98e-06	0.000444	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GCG—pancreatic cancer	6.86e-06	0.000436	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—pancreatic cancer	6.85e-06	0.000436	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SMAD4—pancreatic cancer	6.74e-06	0.000429	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.71e-06	0.000427	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HES1—pancreatic cancer	6.58e-06	0.000419	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GLP1R—pancreatic cancer	6.55e-06	0.000417	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.54e-06	0.000416	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—STK11—pancreatic cancer	6.45e-06	0.00041	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DPYD—pancreatic cancer	6.45e-06	0.00041	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.13e-06	0.00039	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	6.12e-06	0.000389	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.05e-06	0.000385	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.05e-06	0.000385	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.84e-06	0.000372	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD44—pancreatic cancer	5.82e-06	0.00037	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TERT—pancreatic cancer	5.77e-06	0.000367	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.7e-06	0.000363	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOE—pancreatic cancer	5.68e-06	0.000362	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.65e-06	0.000359	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GCG—pancreatic cancer	5.58e-06	0.000355	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMS—pancreatic cancer	5.55e-06	0.000353	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIF1A—pancreatic cancer	5.52e-06	0.000351	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TSC2—pancreatic cancer	5.5e-06	0.00035	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOE—pancreatic cancer	5.39e-06	0.000343	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.38e-06	0.000342	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.36e-06	0.000341	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.32e-06	0.000339	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—STK11—pancreatic cancer	5.25e-06	0.000334	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—pancreatic cancer	5.13e-06	0.000326	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOTCH1—pancreatic cancer	4.97e-06	0.000316	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—pancreatic cancer	4.95e-06	0.000315	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.93e-06	0.000313	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGF—pancreatic cancer	4.81e-06	0.000306	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD44—pancreatic cancer	4.74e-06	0.000301	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.64e-06	0.000295	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.6e-06	0.000293	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GCG—pancreatic cancer	4.54e-06	0.000289	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.51e-06	0.000287	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOE—pancreatic cancer	4.51e-06	0.000287	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CD—pancreatic cancer	4.51e-06	0.000287	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.32e-06	0.000275	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CD—pancreatic cancer	4.27e-06	0.000272	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—STK11—pancreatic cancer	4.27e-06	0.000272	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.27e-06	0.000272	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.25e-06	0.000271	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—pancreatic cancer	4.07e-06	0.000259	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.03e-06	0.000257	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.01e-06	0.000255	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CB—pancreatic cancer	3.93e-06	0.00025	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—pancreatic cancer	3.93e-06	0.00025	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—pancreatic cancer	3.89e-06	0.000248	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CB—pancreatic cancer	3.72e-06	0.000237	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.67e-06	0.000234	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOE—pancreatic cancer	3.67e-06	0.000234	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CD—pancreatic cancer	3.58e-06	0.000228	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.47e-06	0.000221	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTEN—pancreatic cancer	3.4e-06	0.000216	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.31e-06	0.000211	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CTNNB1—pancreatic cancer	3.3e-06	0.00021	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PTEN—pancreatic cancer	3.22e-06	0.000205	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.2e-06	0.000203	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD44—pancreatic cancer	3.12e-06	0.000199	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CB—pancreatic cancer	3.12e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCG—pancreatic cancer	3e-06	0.000191	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOE—pancreatic cancer	2.99e-06	0.00019	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SRC—pancreatic cancer	2.99e-06	0.00019	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.91e-06	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—pancreatic cancer	2.88e-06	0.000183	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NRAS—pancreatic cancer	2.87e-06	0.000183	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.83e-06	0.00018	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—STK11—pancreatic cancer	2.82e-06	0.000179	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.7e-06	0.000172	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTEN—pancreatic cancer	2.7e-06	0.000172	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—pancreatic cancer	2.67e-06	0.00017	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—pancreatic cancer	2.67e-06	0.00017	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—pancreatic cancer	2.62e-06	0.000167	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.6e-06	0.000166	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.54e-06	0.000162	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.52e-06	0.00016	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—pancreatic cancer	2.47e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.42e-06	0.000154	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—pancreatic cancer	2.4e-06	0.000152	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.37e-06	0.000151	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—pancreatic cancer	2.27e-06	0.000145	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.19e-06	0.00014	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—pancreatic cancer	2.1e-06	0.000134	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.07e-06	0.000131	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.05e-06	0.00013	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOE—pancreatic cancer	1.97e-06	0.000125	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—pancreatic cancer	1.96e-06	0.000125	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.9e-06	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—pancreatic cancer	1.86e-06	0.000118	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.79e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.78e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.72e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.56e-06	9.95e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—pancreatic cancer	1.55e-06	9.89e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.55e-06	9.85e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.36e-06	8.67e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.35e-06	8.59e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.26e-06	8.04e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.26e-06	8.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.18e-06	7.49e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.03e-06	6.55e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.31e-07	5.29e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.78e-07	4.32e-05	CbGpPWpGaD
